Abstract Background/Objectives: Cannabidiol (CBD) is a non-intoxicating cannabinoid touted for a variety of medical benefits, including alleviation of anxiety. While…
Abstract Increasing numbers of individuals have access to cannabinoid-based products containing various amounts of delta-9-tetrahydrocannabinol (THC), cannabidiol (CBD), and other…
Abstract The majority of states have fully legalized the use of medical cannabis (MC), and nearly all other states allow…
Abstract Background: Previous studies have demonstrated abnormal white matter (WM) microstructure in recreational cannabis consumers; however, the long-term impact of…
Abstract Background: Evidence suggests cannabidiol (CBD) has anxiolytic properties, indicating potential for novel treatment strategies. However, few clinical trials of…
Abstract This survey study assessed modes of cannabis use endorsed by perimenopausal and postmenopausal individuals and specific menopause-related symptoms indicated…
Abstract Background: To date, no studies have directly assessed potential cannabis use disorder (CUD) in medical cannabis (MC) patients pre-…
Abstract This cohort study examines whether consumption of a high-cannabidiol product resulted in detectable amounts of Δ9-tetrahydrocannabinol metabolites in the…
Abstract Background: Across the nation, growing numbers of individuals are exploring the use of cannabis for medical or recreational purposes,…
Abstract Background: Cannabis concentrates, including dabs, contain extremely high levels of Δ9-tetrahydrocannabinol (THC). Although these products appear to be gaining…